ATE376413T1 - Verkapselung biologisch aktiver komplexe in liposomen - Google Patents

Verkapselung biologisch aktiver komplexe in liposomen

Info

Publication number
ATE376413T1
ATE376413T1 AT00915983T AT00915983T ATE376413T1 AT E376413 T1 ATE376413 T1 AT E376413T1 AT 00915983 T AT00915983 T AT 00915983T AT 00915983 T AT00915983 T AT 00915983T AT E376413 T1 ATE376413 T1 AT E376413T1
Authority
AT
Austria
Prior art keywords
liposomes
encapsulation
biologically active
active complexes
nucleic acids
Prior art date
Application number
AT00915983T
Other languages
English (en)
Inventor
Paul Meers
Tong Shangguan
Donna Cabral-Lilly
Andrew Janoff
Patrick Ahl
Original Assignee
Transave Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transave Inc filed Critical Transave Inc
Application granted granted Critical
Publication of ATE376413T1 publication Critical patent/ATE376413T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT00915983T 1999-03-02 2000-03-01 Verkapselung biologisch aktiver komplexe in liposomen ATE376413T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12236599P 1999-03-02 1999-03-02

Publications (1)

Publication Number Publication Date
ATE376413T1 true ATE376413T1 (de) 2007-11-15

Family

ID=22402271

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915983T ATE376413T1 (de) 1999-03-02 2000-03-01 Verkapselung biologisch aktiver komplexe in liposomen

Country Status (20)

Country Link
US (2) US7491409B1 (de)
EP (1) EP1156783B1 (de)
JP (1) JP2002538096A (de)
KR (1) KR20010112301A (de)
CN (1) CN1349402A (de)
AT (1) ATE376413T1 (de)
AU (1) AU3715900A (de)
BR (1) BR0008711A (de)
CA (1) CA2362485A1 (de)
CZ (1) CZ20013103A3 (de)
DE (1) DE60036861T2 (de)
EA (1) EA200100856A1 (de)
ES (1) ES2295018T3 (de)
HU (1) HUP0200114A2 (de)
IL (1) IL145117A0 (de)
NO (1) NO20014231L (de)
NZ (1) NZ513829A (de)
PL (1) PL351487A1 (de)
WO (1) WO2000051565A1 (de)
ZA (1) ZA200107205B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491409B1 (en) * 1999-03-02 2009-02-17 Transave, Inc. Encapsulation of bioactive complexes in liposomes
WO2002028367A1 (fr) * 2000-10-04 2002-04-11 Kyowa Hakko Kogyo Co., Ltd. Procede de revetement de particules fines avec un film de lipides
NZ529347A (en) * 2001-04-04 2008-01-31 Nordic Vaccine Technology As Use of at least one sterol capable of interacting with a nucleic acid and at least saponin to form immunostimulating complexes ( IMSCO )
US7713942B2 (en) 2001-04-04 2010-05-11 Nordic Vaccine Technology A/S Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
JP4370451B2 (ja) * 2001-09-28 2009-11-25 大塚製薬株式会社 医薬組成物
EP1478341A4 (de) * 2002-01-09 2009-05-20 Transave Inc Wirksame nukleinsäureverkapselung in mittelgrossen liposomen
US20060062839A1 (en) * 2002-01-09 2006-03-23 Elan Pharmaceuticals, Inc. Efficient liposomal encapsulation under mild conditions
US7566535B2 (en) 2002-03-07 2009-07-28 University Of Delaware Enhanced oligonucleotide-mediated nucleic acid sequence alteration
EP1513538A4 (de) * 2002-06-14 2007-08-22 Mirus Bio Corp Neuartige verfahren zum einbringen von polynukleotiden in zellen
CN100531889C (zh) * 2005-01-28 2009-08-26 协和发酵麒麟株式会社 被覆微粒的制备方法
EP1867726A4 (de) * 2005-03-24 2008-09-24 Univ Hokkaido Nat Univ Corp Zur wirksamen zuführung einer gegebenen substanz in den zellkern fähiges liposom
JPWO2007037444A1 (ja) * 2005-09-30 2009-04-16 国立大学法人 北海道大学 目的物質を核内又は細胞内に送達するためのベクター
US20100143937A1 (en) * 2007-05-31 2010-06-10 Sanofi-Aventis ASSAY METHODS FOR IDENTIFYING AGENTS THAT MODIFY THE ACTIVITY OF NAPE-PLD OR Abh4
US8784659B2 (en) * 2007-08-08 2014-07-22 General Electric Company Method for controlling microbial biofilm in aqueous systems
DK2279254T3 (en) 2008-04-15 2017-09-18 Protiva Biotherapeutics Inc PRESENT UNKNOWN LIPID FORMS FOR NUCLEIC ACID ADMINISTRATION
MX359674B (es) 2008-11-10 2018-10-05 Alnylam Pharmaceuticals Inc Lipidos y composiciones novedosas para el suministro de terapeuticos.
EP2449114B9 (de) 2009-07-01 2017-04-19 Protiva Biotherapeutics Inc. Neue lipidformulierungen zur abgabe von therapiemitteln in feste tumore
US20110177147A1 (en) 2010-01-21 2011-07-21 General Electric Company Stable biocidal delivery systems
KR101102834B1 (ko) * 2010-02-24 2012-01-05 충남대학교산학협력단 신규한 리포좀 제조 방법 및 장치
KR101198715B1 (ko) * 2010-05-14 2012-11-13 한국생명공학연구원 핵산 및 친수성 음이온 화합물의 고효율 포획을 위한 비대칭 리포솜 및 이의 제조방법
US9006417B2 (en) 2010-06-30 2015-04-14 Protiva Biotherapeutics, Inc. Non-liposomal systems for nucleic acid delivery
FR2964569B1 (fr) * 2010-09-10 2012-10-19 Ct De Cooperation Internationale En Rech Agronomique Pour Le Dev Cirad Nouveaux liposomes de vaccination genique
WO2012122313A2 (en) * 2011-03-08 2012-09-13 Access Pharmaceuticals, Inc. Targeted nanocarrier systems for delivery of actives across biological membranes
US9758395B2 (en) 2011-04-28 2017-09-12 Aquero Company, Llc Lysine-based polymer coagulants for use in clarification of process waters
KR102194648B1 (ko) 2013-05-17 2020-12-23 쓰리엠 이노베이티브 프로퍼티즈 컴파니 반응 혼합물, 다공성 입자 및 제조 방법
KR102246242B1 (ko) 2013-05-17 2021-04-28 쓰리엠 이노베이티브 프로퍼티즈 컴파니 중합체 복합 입자로부터의 생물 활성제의 방출
WO2020023311A1 (en) * 2018-07-21 2020-01-30 University Of Tennessee Research Foundation Neutral liposomes containing biologically active agents
CA3134828A1 (en) * 2019-03-29 2020-10-08 Glycomine, Inc. Liposomal formulations, and methods of using and preparing thereof
EP3739321B1 (de) * 2019-05-17 2023-03-08 Xtal Concepts GmbH Qualifizierungsverfahren für kryoelektronenmikroskopie-proben sowie dazugehöriger probenhalter
WO2022045009A1 (ja) * 2020-08-24 2022-03-03 国立大学法人山口大学 流体を追跡するための組成物及び流体の追跡方法
AU2022245985A1 (en) 2021-03-22 2023-09-21 Illumina Cambridge Limited Methods for improving nucleic acid cluster clonality
CN113785975B (zh) * 2021-09-09 2023-08-29 天津医科大学 精胺、亚精胺脂质体在抗氧化、抗衰老中的应用
DE102022134188B3 (de) 2022-12-20 2024-03-28 Universität Augsburg - Körperschaft des öffentlichen Rechts Verfahren zur in-situ Erfassung von Änderungen eines Lipidsystems bei dessen Lagerung bei einer Lagertemperatur unterhalb von -60 °C

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723147A (en) 1987-02-23 1998-03-03 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5286634A (en) * 1989-09-28 1994-02-15 Stadler Joan K Synergistic method for host cell transformation
CA2161225C (en) * 1993-04-22 2003-07-01 Sinil Kim Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
US5795587A (en) * 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
WO1998020857A1 (en) * 1996-11-12 1998-05-22 The Regents Of The University Of California Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
US7491409B1 (en) * 1999-03-02 2009-02-17 Transave, Inc. Encapsulation of bioactive complexes in liposomes

Also Published As

Publication number Publication date
AU3715900A (en) 2000-09-21
KR20010112301A (ko) 2001-12-20
IL145117A0 (en) 2002-06-30
WO2000051565A1 (en) 2000-09-08
EP1156783A1 (de) 2001-11-28
EA200100856A1 (ru) 2002-02-28
CZ20013103A3 (cs) 2002-01-16
ZA200107205B (en) 2002-12-02
DE60036861T2 (de) 2008-07-24
ES2295018T3 (es) 2008-04-16
US20090068256A1 (en) 2009-03-12
PL351487A1 (en) 2003-04-22
JP2002538096A (ja) 2002-11-12
BR0008711A (pt) 2002-10-01
DE60036861D1 (de) 2007-12-06
EP1156783B1 (de) 2007-10-24
WO2000051565A9 (en) 2002-02-14
CN1349402A (zh) 2002-05-15
CA2362485A1 (en) 2000-09-08
NO20014231D0 (no) 2001-08-31
NO20014231L (no) 2001-10-03
US7491409B1 (en) 2009-02-17
HUP0200114A2 (hu) 2002-05-29
NZ513829A (en) 2001-09-28
EP1156783A4 (de) 2003-05-21

Similar Documents

Publication Publication Date Title
DE60036861D1 (de) Verkapselung biologisch aktiver komplexe in liposomen
IL140710A0 (en) Pulmonary delivery of active agents
EP1183068A4 (de) Verfahren zur durch elektroporation erleichterte verabreichung aktiver substanzen
AU2002232788A1 (en) Self forming, thermodynamically stable liposomes and their applications
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
EP1015008A4 (de) Verbindungen und zusammensetzungen zur administration aktiver stoffe
BR0314354A (pt) Formação para gentes lipofìlicos
CA2468916A1 (en) A stable oxaliplatin solution formulation
WO2003068144A3 (en) Cytotoxic agents
WO2004000226A3 (en) Liposomes containing biologically active compounds
WO1999013816A3 (en) Liposomal camptothecin formulations
MXPA02012068A (es) Formulaciones liposomales inhibidoras de la timidilato de benzoqunazolina sintasa.
WO2002015959A3 (en) Compounds and compositions for delivering active agents
ITMI20000095A0 (it) Cerotto per la somministrazione locale e transdermica di principi attivi dotati di gruppi anionici ed elettronattrattori
AU7134898A (en) Biodegradable microparticles for the sustained delivery of therapeutic drugs
WO2002043706A3 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
AU2001232238A1 (en) Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
CA2402708A1 (en) Torasemide-containing pharmaceutical preparations
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
WO2001049117A3 (en) An anti-viral lotion composition and a lotioned tissue product
SG142165A1 (en) Biologically active peptides
NZ528544A (en) Formulations comprising entrapped active ingredients and uses thereof
SE9902742D0 (sv) New pharmaceutical formultion
AU2001252246A1 (en) Therapeutically active proteins in plants
AU2001262699A1 (en) Biologically active agents and drugs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties